Yesterday’s News? Qutoutiao Adds Delisting Threat to Growing Headaches

The former highflying news app said it could be kicked off the Nasdaq Global Select Market after the value of its publicly held shares fell below a minimum threshold Key Takeaways: Qutoutiao faces potential delisting after being notified last week that the value of its publicly held shares is too small The cash-strapped company has adopted a cost-cutting strategy over the last two years, and has yet to report its first and second quarter results for this year By Trevor Mo Qutoutiao Inc. (QTT.US) shot to fame as the fastest…

Read More »

Lacking Revenue, Jenscare Scientific Hopes IPO Investors Take Heart in Its Potential

The maker of devices to treat structural heart disease hopes to have its first product approved in the second half of next year as it prepares to list in Hong Kong Key Takeaways: Jenscare Scientific is preparing to raise a reported $30 million in a Hong Kong IPO, even though it doesn’t expect to earn any product-related revenue until the latter half of next year at earliest The company’s valuation reached $1.36 billion last year, but could possibly dive by the time it debuts due to weak overall market sentiment…

Read More »

FAST NEWS: Everest Medicines Hits New Low after New CEO Announcement

The latest: Innovative drug maker Everest Medicines Ltd. (1952.HK) on Monday announced the appointment of Luo Yongqing, formerly president and general manager of Greater China for Brii Biosciences Ltd. (2137.HK), as its new CEO effective immediately. Looking up: Luo worked for two years at Brii Biosciences, and before that was global vice president and general manager of China for U.S. pharma company Gilead (GILD.US), where he helped build the company’s China business. During his time at Gilead he led the clinical development, registration approval and successful launch of eight innovative…

Read More »